Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in people aged 11–55 years.
The CDC advises everyone, including those with HIV, to be “up to date on their meningococcal vaccines" The Centers ... The ...
A vaccine has for the first time been shown ... The bacterium that causes meningitis, Neisseria meningitidis, is a very close relative of the species that causes gonorrhoea - Neisseria gonorrhoeae.
The new vaccine is a combination of GSK’s already ... and Y serogroups (MenABCWY) of the bacteria Neisseria meningitidis. MenABCWY covers five of the six serogroups that cause most disease ...
Attempts to develop a vaccine against gonorrhoea have been largely unsuccessful; however, in 2017 a study showed that vaccination against a related bacterium Neisseria meningitidis (Nm) led to a ...
Neisseria meningitidis spreads through the exchange ... effective method of preventing type C meningitis. There are two vaccines available to help prevent a person from developing type C ...
Hosted on MSN1mon
Meningitis may have a much greater impact on child mortality than previously thoughtVaccines can protect against the most common types of meningitis-causing bacteria, such as Haemophilus influenzae type B (Hib), Streptococcus pneumoniae, and Neisseria meningitidis. Yet ...
ULAN BATOR, Dec. 25 (Xinhua) -- Mongolia's National Center for Communicable Diseases (NCCD) confirmed on Wednesday an outbreak of meningococcal disease, a potentially life-threatening infection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback